Skip to main content
Skip to main content
CLOEU logo

Clover Leaf Capital Corp. (CLOEU) Stock Analysis

DELISTED 2025

What happened to Clover Leaf Capital Corp. (CLOEU) stock?

Clover Leaf Capital Corp. (CLOEU) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.

52-wk range: $8.01 – $15.84
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Clover Leaf Capital Corp. (CLOEU). Clover Leaf Capital Corp. is a shell company focused on merging with a business in the cannabis industry. Currently, the company has minimal operations as it seeks a suitable acquisition target. Sector: Financial services.

Last analyzed: Mar 17, 2026
Clover Leaf Capital Corp. is a shell company focused on merging with a business in the cannabis industry. Currently, the company has minimal operations as it seeks a suitable acquisition target.
Watch the CLOEU film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 38/100 · D

CLOEU: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Bearish
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Clover Leaf Capital Corp. (CLOEU) Financial Services Profile

CEOFelipe MacLean
Employees3
HeadquartersMiami, US
IPO Year2021

Clover Leaf Capital Corp., a shell company incorporated in 2021, is actively seeking a merger, asset acquisition, or similar business combination, primarily targeting the cannabis industry. With a small team and limited operations, its future hinges on identifying and completing a successful transaction.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for CLOEU?

As of Mar 17, 2026 — figures reflect the data available on that date.

Clover Leaf Capital Corp. presents a speculative investment opportunity, contingent on its ability to successfully merge with or acquire a viable cannabis business. With a market capitalization of $0.06 billion and a negative P/E ratio of -68.30, the company's valuation is primarily based on its potential future prospects rather than current earnings. The company's low beta of 0.07 suggests low volatility relative to the market. A successful acquisition could drive significant shareholder value, but the risk remains high due to the competitive nature of the SPAC market and the uncertainties surrounding regulatory developments in the cannabis industry. Investors should carefully consider the management team's experience and track record in identifying and executing successful transactions, as well as the potential for dilution and other risks associated with SPAC investments. The timeline for identifying and completing a merger is uncertain, adding to the speculative nature of this investment.

Based on FMP financials and quantitative analysis

CLOEU Key Highlights

Market capitalization of $0.06 billion, reflecting its status as a small-cap company.

  • Negative P/E ratio of -68.30, indicating that the company is currently not profitable.
  • Beta of 0.07, suggesting low volatility compared to the overall market.
  • The company was incorporated in 2021, making it a relatively new entity in the financial services sector.
  • Focus on the cannabis industry, indicating a targeted approach to identifying potential merger or acquisition targets.

Who Are CLOEU's Competitors?

CLOEU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AOAO Alpha One Inc. $3.55 +0.00% $39.0M 38
ATMS Artemis Therapeutics Inc. $0.50 -73.65% $55.8M 51
BHAC Focus Impact BH3 Acquisition Co $10.55 -52.05% $59.6M 49
IRAA Iris Acquisition Corp $6.43 -8.01% $45.1M 49
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64
APXTW Apex Treasury Corporation $0.35 -5.41% $1.89B 66

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CLOEU's Key Strengths?

Experienced management team.

  • Focus on the high-growth cannabis industry.
  • Access to capital through public markets.

What Are CLOEU's Weaknesses?

Lack of current operations.

  • Dependence on identifying and completing a successful merger.
  • Competition from other SPACs.

What Could Drive CLOEU Stock Higher?

Announcement of a potential merger or acquisition target.

  • Progress in negotiations with potential merger partners.
  • Changes in cannabis industry regulations that could benefit the company.

What Are the Key Risks for CLOEU?

Financial-distress signal — its Altman Z-Score of 0.94 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
  • Failure to identify and complete a successful merger or acquisition.
  • Increased competition from other SPACs.
  • Regulatory uncertainty in the cannabis industry.
  • Limited liquidity on the OTC market.
  • Dependence on the management team's ability to execute its strategy.

What Are the Growth Opportunities for CLOEU?

  • Successful Merger or Acquisition: Clover Leaf Capital Corp.'s primary growth opportunity lies in successfully completing a merger or acquisition with a promising company in the cannabis industry. The global cannabis market is projected to reach $47.2 billion by 2027, presenting a significant opportunity for growth. The timeline for this growth opportunity is dependent on the company's ability to identify and execute a transaction, which could occur within the next 1-3 years. A successful merger could provide access to new markets, technologies, and revenue streams, driving shareholder value.
  • Expansion into New Cannabis Markets: Following a successful merger, Clover Leaf Capital Corp. could pursue expansion into new geographic markets within the cannabis industry. The cannabis market is rapidly evolving, with new states and countries legalizing cannabis for medical and recreational use. This expansion could occur within the next 3-5 years, as the company establishes its presence in existing markets. By expanding into new markets, the company could diversify its revenue streams and reduce its dependence on any single market.
  • Development of New Cannabis Products and Services: Clover Leaf Capital Corp. could invest in the development of new cannabis products and services to meet the evolving needs of consumers. This could include new strains of cannabis, innovative delivery methods, or value-added services such as cannabis-infused products. The timeline for this growth opportunity is ongoing, as the company continuously seeks to innovate and differentiate itself from competitors. By developing new products and services, the company could attract new customers and increase its market share.
  • Strategic Partnerships and Alliances: Clover Leaf Capital Corp. could form strategic partnerships and alliances with other companies in the cannabis industry to expand its reach and capabilities. This could include partnerships with cannabis growers, processors, distributors, or retailers. These partnerships could be formed within the next 1-2 years, as the company seeks to leverage the expertise and resources of other players in the industry. By forming strategic partnerships, the company could accelerate its growth and gain a competitive advantage.
  • Capitalizing on Regulatory Changes: Clover Leaf Capital Corp. could capitalize on favorable regulatory changes in the cannabis industry to expand its business. As more states and countries legalize cannabis, new opportunities will emerge for companies operating in this sector. The timeline for this growth opportunity is dependent on the pace of regulatory change, which is difficult to predict. By staying informed about regulatory developments and adapting its business strategy accordingly, the company could position itself to capitalize on new opportunities as they arise.

What Are CLOEU's Competitive Advantages?

  • Management team's experience in identifying and executing successful transactions.
  • Focus on the cannabis industry, which may provide access to unique opportunities.
  • Access to capital through the public markets.

What Does CLOEU Do?

Clover Leaf Capital Corp. was founded in 2021 and is based in Miami, Florida. It operates as a blank check company, also known as a special purpose acquisition company (SPAC). Clover Leaf Capital Corp. is designed to raise capital through an initial public offering (IPO) with the specific purpose of acquiring or merging with an existing operating company. The company's primary focus is to identify and complete a business combination, which may include a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar transaction, with one or more businesses. Clover Leaf Capital Corp. intends to focus its efforts on companies operating within the cannabis industry, seeking to capitalize on the growth and potential within this sector. As of 2026, Clover Leaf Capital Corp. has minimal operations, with a small team of three employees, and is actively searching for a suitable acquisition target. The success of the company depends heavily on its ability to identify, negotiate, and complete a transaction that will bring value to its shareholders. The company's strategy is to leverage the expertise of its management team to find a promising business in the cannabis sector and facilitate its entry into the public market.

What Products and Services Does CLOEU Offer?

  • Clover Leaf Capital Corp. is a blank check company.
  • It aims to merge with or acquire another company.
  • The company focuses on businesses in the cannabis industry.
  • It seeks to provide a private company access to public markets.
  • It raises capital through an initial public offering (IPO).
  • The company is currently searching for a suitable target company.

How Does CLOEU Make Money?

  • Raise capital through an IPO.
  • Identify and evaluate potential merger or acquisition targets.
  • Complete a business combination with a target company.
  • Generate returns for shareholders through the growth of the acquired company.

What Industry Does CLOEU Operate In?

Clover Leaf Capital Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to access public markets more quickly and efficiently. However, the industry is also characterized by intense competition and regulatory scrutiny. Clover Leaf Capital Corp.'s focus on the cannabis industry aligns with the growing interest in this sector, but also exposes it to the risks and uncertainties associated with the evolving legal and regulatory landscape surrounding cannabis. The success of Clover Leaf Capital Corp. will depend on its ability to differentiate itself from other SPACs and identify attractive acquisition targets in the cannabis industry.

Who Are CLOEU's Key Customers?

  • Investors who participate in the company's IPO.
  • Shareholders who invest in the company's stock.
  • The target company that merges with or is acquired by Clover Leaf Capital Corp.
AI Confidence: 79% Updated: Mar 17, 2026

Company Profile

Clover Leaf Capital Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Miami, US. The company is led by CEO Felipe MacLean. CLOEU has traded publicly since 2021.

F-Score 1/9

Financial Health

Clover Leaf Capital Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.94 places it in the distress zone, a signal of elevated financial risk.

CLOEU Financials

Bull Case vs Bear Case

Bull Case

  • Experienced management team.
  • Focus on the high-growth cannabis industry.
  • Access to capital through public markets.
  • Upcoming: Announcement of a potential merger or acquisition target.

Bear Case

  • Lack of current operations.
  • Dependence on identifying and completing a successful merger.
  • Competition from other SPACs.
  • Potential: Failure to identify and complete a successful merger or acquisition.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

CLOEU Latest News

No recent news available for CLOEU.

Leadership: Felipe MacLean

CEO

Felipe MacLean serves as the CEO of Clover Leaf Capital Corp. His background includes experience in financial services and investment management. He has a track record of identifying and evaluating investment opportunities in various sectors. MacLean's expertise lies in structuring and executing complex transactions, including mergers and acquisitions. He is responsible for leading the company's efforts to identify and complete a business combination with a suitable target company in the cannabis industry.

Track Record: Under Felipe MacLean's leadership, Clover Leaf Capital Corp. has focused on identifying potential merger targets within the cannabis sector. While the company has not yet completed a transaction, MacLean has overseen the evaluation of numerous opportunities and has worked to build relationships with key players in the industry. His strategic decisions have positioned the company to capitalize on the growth potential of the cannabis market.

CLOEU OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Clover Leaf Capital Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may be subject to limited regulatory oversight and may not provide the same level of transparency as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • OTC Tier: OTC Other
Liquidity: Liquidity on the OTC market can be limited, potentially leading to wider bid-ask spreads and difficulty in executing large trades. The trading volume for Clover Leaf Capital Corp. on the OTC market is likely to be lower compared to companies listed on major exchanges, which could make it more challenging to buy or sell shares quickly without affecting the price. Investors should be aware of these liquidity constraints when considering an investment in CLOEU.
OTC Risk Factors:
  • Limited liquidity on the OTC market.
  • Lack of regulatory oversight.
  • Potential for limited financial disclosure.
  • Higher risk of fraud or manipulation.
  • Increased price volatility.
Due Diligence Checklist:
  • Verify the company's financial statements.
  • Research the background of the management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Understand the risks associated with investing in OTC stocks.
  • Check for any red flags or warning signs.
  • Consult with a financial advisor.
Legitimacy Signals:
  • Company is registered with the SEC.
  • Management team has relevant experience.
  • Company has a clear business plan.
  • Company is actively seeking a merger or acquisition target.
  • Company has a website and investor relations materials.

Common Questions About CLOEU (Financial Services)

What happened to Clover Leaf Capital Corp. (CLOEU) stock?

Clover Leaf Capital Corp. (CLOEU) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.

Can I still buy CLOEU shares?

No. CLOEU stopped trading on public markets in July 2025, so the shares are not available through a broker. Anything you see quoted for CLOEU elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CLOEU stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Clover Leaf Capital Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Clover Leaf Capital Corp. do?

Clover Leaf Capital Corp. is a special purpose acquisition company (SPAC) focused on identifying and merging with a company in the cannabis industry. As a SPAC, it has no operating business of its own but raises capital through an IPO with the intent of acquiring a private company, thereby taking it public.

What do analysts say about CLOEU stock?

As of March 17, 2026, there is no available analyst coverage for Clover Leaf Capital Corp. (CLOEU). Given its status as a shell company seeking a merger target, traditional analyst ratings and price targets are not applicable. The stock's performance is primarily driven by speculation surrounding potential acquisition targets and the overall sentiment towards the cannabis industry.

What are the main risks for CLOEU?

The primary risk for Clover Leaf Capital Corp. lies in its dependence on identifying and completing a successful merger or acquisition within the cannabis industry. The SPAC market is highly competitive, and there is no guarantee that the company will be able to find a suitable target or negotiate favorable terms.

How is Clover Leaf Capital Corp. positioned to capitalize on the evolving cannabis market?

Clover Leaf Capital Corp. is strategically positioned to capitalize on the evolving cannabis market by focusing its acquisition efforts on companies within this sector. The company aims to leverage its management team's expertise and access to capital to identify and acquire a promising cannabis business, providing it with access to public markets and resources for growth.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • AI analysis is pending and may provide additional insights.
Data Sources

Popular Stocks

More Stocks We Cover